IVERIC bio (FRA:O2T) Total Stockholders Equity : €445.56 Mil (As of Mar. 2023)

View and export this data going back to 2013. Start your Free Trial

What is IVERIC bio Total Stockholders Equity?

IVERIC bio's Total Stockholders Equity for the quarter that ended in Mar. 2023 was €445.56 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. IVERIC bio's Book Value per Share for the quarter that ended in Mar. 2023 was €3.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. IVERIC bio's Debt-to-Equity for the quarter that ended in Mar. 2023 was 0.20.

IVERIC bio Total Stockholders Equity Historical Data

The historical data trend for IVERIC bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVERIC bio Total Stockholders Equity Chart

IVERIC bio Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

108.96

105.48

157.47

319.07

504.72

IVERIC bio Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Stockholders Equity	Get a 7-Day Free Trial															302.50	277.13	262.12	504.72	445.56

IVERIC bio (FRA:O2T) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

IVERIC bio's Book Value per Share for the quarter that ended in Mar. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(445.561	-	0)	/	137.25
	=	3.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

IVERIC bio's Debt-to-Equity for the quarter that ended in Mar. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.723	+	90.586)	/	445.561
	=	0.20

IVERIC bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of IVERIC bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

IVERIC bio (FRA:O2T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IVERIC bio Inc (FRA:O2T) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Sylvan Way, Parsippany, New Jersey, USA, 07054

Website

https://www.ivericbio.com

IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

IVERIC bio (FRA:O2T) Headlines

No Headlines